May 11 Solar Capital Ltd
* Repays its $75 million of 5.875 pct senior secured notes; reduces average interest expense
* Repayment was prefunded through company's recent $50 million and $100 million issuances of unsecured senior notes due May 8, 2022 Source text for Eikon: Further company coverage:
Novartis gets European OK for biosimilar of Amgen's Enbrel
ZURICH, June 27 Novartis's generics unit Sandoz said the European Commission approved Erelzi, its biosimilar to Amgen's Enbrel, to treat inflammatory diseases such as rheumatoid arthritis, psoriasis, and psoriatic arthritis.
BRIEF-JCDecaux and América Móvil to create a joint venture in Mexico
* JCDECAUX AND AMÉRICA MÓVIL TO CREATE A JOINT VENTURE BY MERGING THEIR OOH BUSINESSES IN MEXICO